Bharat Book Bureau

Archives for Diseases

“Drug Discovery and Preclinical Molecules by Therapy Area – Innovation Focuses on Stem Cell Therapies and Gene Therapies”, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection, Cardiovascular Disease and Oncology therapeutic markets. The report analyzes the early stage… » read more

Posted by bharatbook

The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. General information on the lung cancer market, as well as sales of leading drugs and therapies are provided. http://www.bharatbook.com/detail.asp?id=219236&rt=Disease-and-Therapy-Review-Lung-Cancer.html… » read more

Posted by bharatbook

Sociable Pharma conducted in-depth primary research in the US and across Europe with six key opinion leaders in rheumatoid arthritis (RA) to understand how changes will impact therapy use in the future. A key theme in our research is the management and implementation of ‘step-up’ treatment strategies to optimize the timing of effective forms of… » read more

Posted by bharatbook

Sociable Pharma conducted in-depth primary research in the US and across Europe with seven key opinion leaders in juvenile idiopathic arthritis (JIA) to understand how therapy use will change in the future. A key theme in our research is the management and implementation of ‘step-up’ treatment strategies to optimize the timing of effective forms of… » read more

Posted by bharatbook

Sociable Pharma conducted in-depth primary research in the US and across Europe with seven key opinion leaders to understand how these changes will impact therapy use in the future. We also gauged opinion during the European Respiratory Society’s 2011 Annual Congress on the impact that new clinical data for existing and pipeline products will have… » read more

Posted by bharatbook

Sociable Pharma conducted in-depth primary research in the US and across Europe with six key opinion leaders to understand how these changes will impact therapy use in the future. We also gauged opinion during the European Respiratory Society’s 2011 Annual Congress on the impact that new clinical data for existing and pipeline products will have… » read more

Posted by bharatbook

Pharmaceutical and healthcare report, “Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global cystic fibrosis market. The report identifies the key trends shaping and driving the global cystic fibrosis market. The report also provides insight on the prevalent competitive landscape and the emerging… » read more

Posted by bharatbook

Discover potential IBD drug revenues at total world, submarket, product and national levels. Through our research and analysis we aim to save you time and help in your decisions. See how drugs such as Remicade, Humira, Cimzia, Asacol, Pentasa and Entocort can perform to 2021, finding potential revenues. How will competition affect the bowel disorder… » read more

Posted by bharatbook

The Parkinson’s Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the Parkinson’s Disease market, as well… » read more

Posted by bharatbook

The Heart Failure Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the heart failure market, as… » read more

Posted by bharatbook